company background image
HIQ

HITIQ ASX:HIQ Stock Report

Last Price

AU$0.028

Market Cap

AU$7.5m

7D

-3.4%

1Y

-77.6%

Updated

27 Jan, 2023

Data

Company Financials

HIQ Stock Overview

HitIQ Limited engages in development and commercialization of concussion management technology in Australia.

HIQ fundamental analysis
Snowflake Score
Valuation1/6
Future Growth0/6
Past Performance0/6
Financial Health2/6
Dividends0/6

My Notes

New

Notes are coming soon

HITIQ Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for HITIQ
Historical stock prices
Current Share PriceAU$0.028
52 Week HighAU$0.13
52 Week LowAU$0.023
Beta0
1 Month Change7.69%
3 Month Change-31.71%
1 Year Change-77.60%
3 Year Changen/a
5 Year Changen/a
Change since IPO-87.83%

Recent News & Updates

Recent updates

Shareholder Returns

HIQAU Healthcare ServicesAU Market
7D-3.4%5.0%0.6%
1Y-77.6%26.5%5.4%

Return vs Industry: HIQ underperformed the Australian Healthcare Services industry which returned 26.5% over the past year.

Return vs Market: HIQ underperformed the Australian Market which returned 5.4% over the past year.

Price Volatility

Is HIQ's price volatile compared to industry and market?
HIQ volatility
HIQ Average Weekly Movement35.1%
Healthcare Services Industry Average Movement9.8%
Market Average Movement8.5%
10% most volatile stocks in AU Market15.9%
10% least volatile stocks in AU Market3.5%

Stable Share Price: HIQ is more volatile than 90% of Australian stocks over the past 3 months, typically moving +/- 35% a week.

Volatility Over Time: HIQ's weekly volatility has increased from 23% to 35% over the past year.

About the Company

FoundedEmployeesCEOWebsite
201525Mike Vegarhttps://hitiq.com

HitIQ Limited engages in development and commercialization of concussion management technology in Australia. Its Nexus software provides comprehensive head impact data and analysis to make informed decisions to improve the quality of care for athletes. It also offers CoVR, a virtual reality based cognitive and oculomotor assessment platform, which identifies impairments across domains, such as hand-eye coordination, memory, and decision making; and CSX that provides an easy to use, sideline concussion assessment tool, which produces a digital record that can be shared with medical professionals, family, and organizations to take coordinated athlete care.

HITIQ Limited Fundamentals Summary

How do HITIQ's earnings and revenue compare to its market cap?
HIQ fundamental statistics
Market CapAU$7.47m
Earnings (TTM)-AU$6.95m
Revenue (TTM)AU$1.64m

4.5x

P/S Ratio

-1.1x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
HIQ income statement (TTM)
RevenueAU$1.64m
Cost of RevenueAU$4.29m
Gross Profit-AU$2.64m
Other ExpensesAU$4.30m
Earnings-AU$6.95m

Last Reported Earnings

Jun 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)-0.026
Gross Margin-160.78%
Net Profit Margin-422.57%
Debt/Equity Ratio184.1%

How did HIQ perform over the long term?

See historical performance and comparison